论文部分内容阅读
目的探讨文拉法辛合并米氮平治疗女性更年期综合征的疗效。方法对52例女性更年期综合征患者应用汉密尔顿抑郁量表(HAMD)和汉密尔顿焦虑量表(HAMA)进行症状评估,并给予文拉法辛和米氮平治疗,观察治疗效果。结果治疗2、4、8周后HAMD、HAMA评分均比治疗前显著下降(P<0.01)。结论应用文拉法辛合并米氮平治疗女性更年期综合征疗效显著,且未见明显不良反应。
Objective To investigate the efficacy of venlafaxine combined with mirtazapine in the treatment of female climacteric syndrome. Methods Fifty-two patients with menopausal syndrome were evaluated with Hamilton Depression Scale (HAMD) and Hamilton Anxiety Scale (HAMA), and treated with venlafaxine and mirtazapine. The therapeutic effect was observed. Results HAMD and HAMA scores decreased significantly after treatment for 2, 4 and 8 weeks (P <0.01). Conclusion The application of venlafaxine combined with mirtazapine treatment of menopausal syndrome significant effect, and no significant adverse reactions.